CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 138 filers reported holding CLOVIS ONCOLOGY INC in Q1 2014. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $530,000 | -72.7% | 15,142 | -28.3% | 0.15% | -59.9% |
| Q3 2015 | $1,943,000 | -20.3% | 21,129 | -23.8% | 0.37% | +61.7% |
| Q2 2015 | $2,438,000 | -2.1% | 27,743 | -17.3% | 0.23% | -2.1% |
| Q1 2015 | $2,490,000 | +26.8% | 33,544 | -4.3% | 0.24% | +25.0% |
| Q4 2014 | $1,963,000 | +47.0% | 35,046 | +19.1% | 0.19% | +36.2% |
| Q3 2014 | $1,335,000 | -5.9% | 29,435 | -14.1% | 0.14% | +13.1% |
| Q2 2014 | $1,419,000 | -46.6% | 34,275 | -10.6% | 0.12% | -43.8% |
| Q1 2014 | $2,657,000 | -64.6% | 38,355 | -69.2% | 0.22% | -64.7% |
| Q4 2013 | $7,496,000 | -0.8% | 124,372 | +0.0% | 0.62% | -12.8% |
| Q3 2013 | $7,559,000 | -63.6% | 124,328 | -59.9% | 0.70% | -66.7% |
| Q2 2013 | $20,787,000 | – | 310,340 | – | 2.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |